DavidStephenGeldmacherMDFACP

Neurology • Birmingham, AL

Dementia & Geriatrics

Director, Division of Memory Disorders and Behavioral Neurology -University of Alabama-Birmingham

Join to view full profile

Dr. Geldmacher is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Geldmacher's full profile

Already have an account?

Office
1717 6th Ave S
Birmingham, AL 35233
Phone+1 800-822-8816

Summary

Director, Division of Memory Disorders and Behavioral Neurology

Education & Training

Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Neurology, 1987 - 1990
The MetroHealth System/Case Western Reserve UniversityInternship, Internal Medicine, 1986 - 1987
SUNY Upstate Medical UniversityClass of 1986

Certifications & Licensure

NJ State Medical License 1991 - Present
AL State Medical License 2011 - 2024
VA State Medical License 2002 - 2024
OH State Medical License 1989 - 2003
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss Start of enrollment: 2014 Feb 28
Completed
Phase 3
Multiple Ascending Dose Study of Intravenously Administered BMS-986168 (BIIB092) in Patients With Progressive Supranuclear Palsy Start of enrollment: 2015 Oct 02
Completed
Phase 1
Improving Family Quality of Life Through Training to Reduce Care-Resistant Behaviors by People With AD and TBI Start of enrollment: 2017 Feb 01
Completed
Not Applicable

Publications & Presentations

PubMed

734 citations
Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis
Yasser Iturria-Medina, Roberto C. Sotero, Paule-Joanne Toussaint, José María Mateos-Pérez, Alan C. Evans
Nature Communications. 2016-06-21
87 citations
Characterizing cognitive aging in humans with links to animal models.
Gene E. Alexander, Lee Ryan, Dawn Bowers, Thomas C. Foster, Jennifer L. Bizon
Frontiers in Aging Neuroscience. 2012-09-12
78 citations
Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients With Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndro...
Richard M. Tsai, Zachary A. Miller, Mary Koestler, Julio C. Rojas, Peter A. Ljubenkov
JAMA Neurology. 2020-02-01

Press Mentions

UAB Researchers Develop New Cognitive Screening ToolMarch 14th, 2019
Men: Start Your Path to a Healthier You with 7 TipsJune 13th, 2017
Focus on Alzheimer’s Disease Shifts to PreventionApril 11th, 2017
Join now to see all

Grant Support

Pioglitazone In Alzheimer'S Disease ProgressionNational Institute On Aging2002–2003
Core--ClinicalNational Institute On Aging2000–2002
Pioglitazone In Alzheimer'S Disease ProgressionNational Institute On Aging2001